Table Of Content

Journal of Internal Medicine 1993; 233: 505-508 Author Index Agardh C-D, see Torffvit & Agardh, 131; Apelqvist, 485 response and associated lipoprotein abnormalities Aken’ova YA, see Hedo et al., 467 accompanying lymphoma (Case report), 201 Akesson B, see Callmer et al., 53 Blennow K, see Landin et al., 357 Alberti, KGMM, see Tuomilehto et al., 198 Boissonnat P, see de Lorgeril et al., 343 Amlie JP. New trends in the diagnosis and treatment of cardiac Bolao F, see Podzamczer et al., 247 arrythmias (Editorial), 429 Bondjers G, see Berglund et al., 173 Andersen, J, see Becker et al., 165 Bottiger LE. Journal of Internal Medicine—a progress report Andersson DKG, see Nilsson et al., 239 (Editorial), 5 Andersson OK, see Nilsson et al., 239 Budayer AA, see Marino et al., 205 Andersson P-E, see Nilsson et al., 239 Bugianesi E, see Bianchi et al., 385 Andreasson A, see Eggertsen et al., 351 Angelin B, see Berglund et al., 173 Cabana VC, see Blackman et al., 201 Apelgvist J, Larsson J, Agardh C-D. Long-term prognosis for Callejas JM, see Monreal et al., 233 diabetic patients with foot ulcers, 485 Callmer E, Riboli E, Saracci R, Akesson B, Lindgiirde F. The Arias A, see Monreal et al., 233 Malm6 Diet and Cancer Study (Minisymposium). Dietary Asp AA, see Marino et al., 205 assessment methods evaluated in the Malm6 food study, Astrém M, see Landin & Astrém, 299 53 Astudillo A, see Caminal et al., 277 Caminal L, Castellanos E, Mateos V, Astudillo A, Moreno C, Attvall S, Fowelin J, Lager I, von Schenk H, Smith U. Smoking Dieguez MA. Hyperammonaemic encephalopathy as the induces insulin resistance—a potential link with the insulin presenting feature of IgD multiple myeloma (Case report), resistance syndrome, 327 Pig Axdorph U, Laurell G, Bjérkholm M. Monitoring of hearing Canadian—European Randomized Control Trial Group, see during treatment of leukaemia with special reference to the Nielsen et al., 471 use of amikacin, 401 Carlsson J, see Lovqvist et al., 215 Carrascosa M, see Castrillon et al., 89 Bagger JP, see Jensen et al., 125 Casanova A, see Podzamczer et al., 247 Bar-On H, see Berkman et al., 295 Castellanos E, see Caminal et al., 277 Becker U, Andersen J, Skovgaard Poulsen H, Horn T. Hepatic Castrillon JLP, Mediavilla A, Méndez MA, Cavada E, Carracosa cytosolic oestrogen receptors in patients with liver disease, M, Valle R. Syndrome of inappropriate antidiuretic hormone 165 secretion (SIADH) and enalapril (Case report), 89 Berger, M, see Mulhauser & Berger, 321 Cavada E, see Castrillon et al., 89 Berglund G, see Pero et al., 63, 69; Fagerberg et al., 477 Chitson P, see Tuomilehto et al., 187 Berglund G. The Malm6 Diet and Cancer Study. Design, Christie NT, see Pero et al., 69 biological bank and biomarker programme (Minisymposium), Clotet B, see Podzmczer et al., 247 39 Conn HO. Animal versus vegetable protein diet in hepatic Berglund G, Elmstahl S, Janzon L, Larsson SA. The Malmo Diet encephalopathy (Editorial), 369 and Cancer Study. Design and feasibility (Minisymposium), Cosma GN, see Pero et al., 69 45 Craig K, see Tan et al., 315 Berglund L, Wiklund O, Eggertsen G, Olofsson S-O, Eriksson M, Creemers GJ, Van Boven WPL, Lowenberg, B, Van der Heul C. Lindén T, Bondjers G, Angelin B. Apolipoprotein E Azathioprine-associated red pure cell aplasia (Case report) phenotypes in familial hypercholesterolaemia: importance for 85 expression of disease and response to therapy, 173 Bergstrém J. Frontiers in medicine. New aspects of Dale J, see Kontny et al., 139 erythropoietin treatment, 445 Danish Study Group on Verapamil in Myocardial Infarction, see Berkman N, Meirow D, Katzir Z, Bar-On H. Acute renal failure Jespersen et al., 33 due to carnitine palmitoyltransferase deficiency (Case report), Del Rio A Rodriguez-Villamil JL. Metabolic effects of strict salt 295 restriction in essential hypertensive patients, 409 Bhat D, see Koul et al., 463 Denayer Ph, see Unger et al., 435 Bianchi GP, Marchesini G, Fabbri A, Rondelli A, Bugianesi E, Dieguez MA, see Caminal et al., 277 Zoli M, Pisi E. Vegetable versus animal protein diet in van Doormaal, see Kors et al., 255 cirrhotic patients with chronic encephalopathy. A Dorup I, Skajaa K, Thybo NK. Oral magnesium randomized cross-over comparison, 385 supplementation restores the concentrations of magnesium, Bianchi Porro G, Parente F. Opportunistic infections of the potassium and sodium-potassium pumps in skeletal muscle oesophagus in AIDS patients: clinical and therapeutic of patients receiving diuretic treatment, 117 problems (Minireview), 107 Dowse, G, see Tuomilehto et al., 187 Bjérkholm M, see Axdorph et al., 401 Dureau G, see de Lorgeril et al., 343 Blackman JD, Cabana VC, Mazzone T. The acute phase Durojaiye AO, see Hedo et al., 467 506 AUTHOR INDEX Echevarria S, see Farifias et al., 365 Hughes NK, see Gallicchio et al., 259 Eggertsen G, see Berglund et al., 173 Hultcrantz R, Gabrielsson N. Patients with peristent elevation Eggertsen R, Andreasson A, Hedner T, Karlberg BE, Hansson L. of aminotransferases; investigation with ultrasonography, Effect of coffee on ambulatory blood pressure in patients with radionuclide imaging and liver biopsy, 7 treated hypertension, 351 Hurt RD. Nicotine dependence—treatment for the 1990s Bide I, see Os et al., 13 (Editorial), 307 Eiskjzer H, see Jensen et al., 125 Hven PE, see Jespersen et al., 33 Elmstahl S, see Berglund et al., 45; Pero et al., 63 Emanuelsson H, see Lovqvist et al., 215 Ivarsson S-A, Eriksson S, Kockum I, Lernmark A, Lindgren §S, Eriksson M, see Berglund et al., 173 Nilson KO, Sundkvis. HLA-DR3, DQ2 homozygosity in two Eriksson S, see Ivarsson et al., 281 patients with insulin-dependent diabetes mellitus Eriksson T, see Myrenfors et al., 113 superimposed with ulcerative colitis and primary sclerosing cholangitis (Case report), 281 Fabbri A, see Bianchi et al., 385 Fagerberg B, Lindstedt G, Berglund G. Effects of alcohol intake Jacobsen EL, Jacobsen MK. The Malm6 Diet and Cancer Study and obesity on serum liver enzyme activity in obese men (Minisymposium). A biomarker for the assessment of niacin with mild hypertension, 477 nutriture as a potential preventive factor in carcinogenesis, Fagerhol MK, see Leren et al., 195 59 Fareed D, see Tuomilehto et al., 187 Jacobsen MK, see Jacobsen & Jacobsen, 59 Farinas MC, Echevarria S, Sampredo I, Gonzalez A, Pérez del Jakesz RJ, see Steger et al., 499 Molino A, Gonzalez-Marcias J. Renal failure due to Janzon L, see Berglund et al., 45; Pero et al., 63, 69 sulphadiazine in AIDS patients with cerebral toxoplasmosis Jauhiainen M, see Lehto et al., 179 (Case report), 365 Jensen JD, Eiskjzar H, Bagger JP, Pedersen EB. Elevated level of Fowelin J, see Attvall et al., 327 erythropoietin in congestive heart failure. Relationship to Freedman L, see Schatzkin et al., 75 renal perfusion and plasma renin, 125 Frenkel K, see Pero et al., 69 Jespersen CM, Hagerup L, Hollander N, Hven PE, Linde, NC, Nielsen J, Steinmetz E, the Danish Study Group. Does Gabrielsson N, see Hultcrantz & Gabielsson, 7 exercise-induced ST-segment depression predict benefit of Gahrton G, see Gratwohl et al., 333 medical intervention in patients recovering from acute Gallicchio VS, Hughes NK, Tse KF. Modulation of the myocardial infarction?, 33 haemopoietic toxicity associated with zidovudine in vivo with Jespersen CM, Hagerup L, Hollander N, Launberg, J, Linde NC, lithium carbonate, 259 Steinmetz E. Exercise-provoked ST-segment depression and Garcia P, see Podzamcezer et al., 247 prognosis in patients recovering from acute myocardial Gareeboo H, see Tuomilehto et al., 187 infarction, 27 Garte SJ, see Pero et al., 69 Jonckheer MH, see Unger et al., 435 Gnant MFX, see Steger et al., 499 Jorgensen P, Hansen PR. Antiphospholipid antibodies and Goldman JM. Bone marrow transplantation in Europe—can the ischaemic heart disease (Case report), 291 geographical differences be explained? (Editorial), 311 Goldman JM, see Gratwohl et al., 333; Hoyle & Goldman, 419 Karlberg BE, see Eggertsen et al., 351 Gonzalez A, see Farinas et al., 365 Katzir Z, see Berkman et al., 295 Gonzalez-Macias J, see Farinas et al., 365 Khanduri P, see Nayyar et al., 81 Gottfries C-G, see Landin et al., 357 Kjeldsen SE, see Os et al., 13 Gratwohl A, Hermans J, Goldman JM, Gahrton G. Bone Kockum I, see Ivarsson et al., 281 marrow transplantation in Europe: major geographical Koivisto VA, Yki-Jaérvinen H. Fructose and insulin sensitivity in differences, 333 patients with type 2 diabetes, 145 Gudiol F, see Podzamczer et al., 247 Kontny F, Dale J, Nesvold A, Lem P, Soberg T. Left ventricular Guidollet J. see de Lorgeril et al., 343 thrombosis and arterial embolism in acute anterior myocardial infarction, 139 Hagerup L, see Jespersen et al., 27, 33 Kors JW, van Doormaal JJ, de Monchy JGR. Anaphylactoid Hansen PR, see Jergensen & Hansen, 291 shock following Hymenoptera sting as a presenting symptom Hansson L, see Eggertsen et al., 351 of systemic mastocytosis, 255 Hedner T, see Eggertsen et al., 351 Koul PA, Saleem D, Bhat D. Sporadic distal renal tubular Hedo CC, Aken’ova YA, Okpala IE, Durojaiye AO, Salimonu LS. acidosis and periodic hypokalaemic paralysis in Kashmir, Acute phase reactants and severity of homozygous sickle cell 463 disease, 467 Hermans J, see Gratwohl et al., 333 Lafoz E, see Monreal et al., 233 Herzlich BC. Reversal of apparent AIDS dementia complex Lager I, see Attvall et al., 327 following treatment with vitamin B,, (Case report), 495 Lambert M, see Unger et al., 435 Hjermann I, see Os et al., 13 Lande K, see Os et al., 13 Hollander N, see Jespersen et al., 27, 33 Landin B, Astroém M. Unstable haemoglobin causing haemolytic Horn T, see Becker et al., 165 anaemia: de novo mutation in Sweden identified by PCR Hoyle C, Goldman JM. Pyomyositis in a patient with myeloma (Case report), 299 responding to antibiotics alone (Case report), 419 Landin K, Blennow K, Wallin A, Gottfries C-G. Low blood AUTHOR INDEX 507 pressure and blood glucose levels in Alzheimer’s disease. Marosi C, see Steger et al., 499 Evidence for a hypometablic disorder? , 357 Marsden JS, see Marino et al., 205 Langer L, see Larsson et al., 493 Martin TJ. Parathyroid hormone-related protein (Editorial), 1 Larsson GB, Langer L, Nassberger L. Thiazide-induced kidney Martorell A, see Monreal et al., 233 damage with circulating antibodies against myeloperoxidase Mateos V, see Caminal et al., 277 and cardiolipin (Case report), 493 Mathew G, see Nayyar et al., 81 Larsson J, see Apelqvist J, 485 Mazzone T, see Blackman JD et al., 201 Larsson SA, see Berglund et al., 45; Pero et al., 63 Mediavilla A, see Castrillon et al., 89 Lassen JF, Lassen NF, Skov J. Hallucinogenic mushroom use by Meirow D, see Berkman et al., 295 Danish students: pattern of consumption, 111 Melin T, see Prytz & Melin, 21 Lassen NF, see Lassen et al., 111 Méndez MA, see Castrillon et al., 89 Launbjerg J, see Jespersen et al., 27, 33 Miettinen H, see Lehto et al., 179 Laurell, G, see Axdorph et al., 401 Min Z, see Tuomilehto et al., 187 Lehto S, Palomaki P, Miettinen H, Penttila, Salomaa V, Mogensen L. Fibrillating atria—a sizable problem, or rather, Tuomilehto J, Jauhiainen M, Pyérala K. Serum cholesterol atrial fibrillation a striking probiem (Editorial), 373 and high density lipoprotein cholesterol distributions in Molstad P. Prognostic significance of type and location of a patients with acute myocardial infarction and in the general first myocardial infarction, 393 population of Kuopio Province, Eastern Finland, 179 de Monchy JGR, see Kors et al., 255 Lem P, see Kontny et al., 39 Monreal M, Martorell A, Callejas JM, Valls R, Llamazares JF, Lenz, K, see Steger et al., 499 Lafoz E, Arias A. Venographic assessment of deep vein Leren, P, see Leren TP et al., 195 thrombosis and risk of developing post-thrombotic syndrome: Leren TP, Fagerhol MK, Leren P. Sixteen years of plasma a prospective study, 233 exchange in a homozygote for familial hypercholesterolaemia Moreno C, see Caminal et al., 277 (Case report), 195 Miilhauser I, Berger M. Diabetes education and insulin Lernmark A, see Ivarsson et al., 281 therapy: when will they ever learn? (Review), 321 Li N, see Tuomilehto et al., 187 Myrenfors PG, Eriksson T, Sandstedt CS, Sjoberg G. Lindblad U, Rastam L, Ranstam J. Stroke morbidity in patients Moclobemide overdose, 113 treated for hypertension—The Skaraborg Hypertension Project, 155 Nassberger L, see Larsson et al., 493 Linde NC, see Jespersen et al., 27, 33 Nayyar V, Ramakrishna B, Matthew G, Williams RR, Khanduri Lindeberg S, Lundh B. Apparent absence of stroke and P. Response to antituberculous chemotherapy after ischaemic heart disease in a traditional Melanesian island: a splenectomy (Case report), 81 clinical study in Kitava, 269 Nerup J, see Nielson et al., 471 Lindén T, see Berglund et al., 173 Nesvold A, see Kontny et al., 139 Lindgarde F, see Callmer et al., 53 Nielsen J, see Jespersen et al., 33 Lindgren S, see Ivarsson et al., 281 Nielsen OJ, Mandrup-Poulsen T, Nerup J, the Canadian— Lindstedt G, see Fagerberg et al., 477 European Randomized Control Trial Group. Deficiency of Lindstrém FD, see Locht & Lindstrém, 287 erythropoietin is not responsible for the anaemia associated Lithell, H, see Nilsson et al., 239 with cyclosporin treatment of insulin-dependent diabetes Llamazares JF, see Monreal et al., 233 mellitus, 471 Locht, H, Lindstr6ém FD. Severe skin necrosis following warfarin Nilsson J, see Lovqvist et al., 215 therapy in a patient with protein C deficiency (Case report), Nilsson KO, see Ivarsson et al., 281 287 Nilsson P, Andersson DKG, Andersson P-E, Schwan A, Osylind Loire R, see de Logeril et al., 343 B, Malmborg R, Lithell H, Andersson OK. Cardiovascular risk de Lorgeril M, Loire R, Guidollet J, Boissonnat P, Dureau G, factors in treated hypertensives—a nation-wide, cross- Renaud S. Accelerated coronary artery disease after heart sectional study in Sweden, 239 transplantation: the role of enhanced platelet aggregation Nolan J, see Tan et al., 415 and thrombosis, 343 Nordby G, see Os et al., 13 Lévqvist A, Emanuelsson H, Nilsson J, Lundqvist H, Carlsson J. Nordey A. Haemostatic factors in coronary heart disease Pathophysiological mechanisms for restenosis following (Review), 377 coronary angioplasty: possible preventive alternatives (Review), 215. Okpaia IE, see Hedo et al., 467 Lowenberg B, see Creemers et al., 85 Oliver MF. Organization of a clinical trial (Editorial), 211 Lundh B, see Lindeberg & Lundh, 269 Olofsson S-O, see Berglund et al., 173 Lundqvist H, see Lovqvist et al., 215 Olsson A, see Pero et al., 63, 69 Olsson AG. The clinical importance of silent ischaemia during Mader RM, see Steger et al., 499 exercise—new insights in different stages of cvronary heart Malmborg R, see Nilsson et al., 239 disease (Review), 315 Mandrup-Poulsen T, see Nielsen et al., 471 Olsson I. The cytokine network (Editorial), 103 Marchesini GP, see Bianchi et al., 385 Os I. Sex differences in essential hypertension, 13 Marino MT, Asp AA, Budayer AA, Marsden JS, Strewler GJ. Ostlind B, see Nilsson et al., 239 Hypercalcaemia and elevated levels of parathryoid hormone- related protein in cutaneous squamous/basal cell carcinoma Pagerols X, see Podzamczer et al., 247 (Case report), 205 Palomiki P, see Lehto et al., 179 508 AUTHOR INDEX Parente F, see Bianchi Porro & Parente, 107 Skov J, see Lassen et al., 111 Pedersen EB, see Jensen et al., 125 Skovgaard Poulsen H, see Becker et al., 165 Penttila I, see Lehto et al., 179 Smith U, see Attvall et al., 327 Pérez del Molino A, see Farinas et al., 365 Smulson ME, see Pero et al., 69 Pero RW, Berglund G, Christie NT, Cosma GN, Frenkel K, Soberg T, see Kontny et al., 39 Garte SJ, Janzon L, Olsson A, Seidegard J, Smulson ME, Troll Steger GG, Mader RM, Gnant MFX, Marosi C, Lenz K, Jakesz R. W. The Malm6 Diet and Cancer Study (Minisymposium). The GM-CSF in the treatment of a patient with severe Malm6 biomarker programme, 69 methotrexate intoxication (Case report), 499 Pero RW, Olsson A, Berglund G, Janzon L, Larsson SA, Steinberg D. Modified forms of low-density lipoprotein and Elmstah] S. The Malm6 Diet and Cancer Study atherosclerosis (Review), 227 (Minisymposium). The Malm6 biological bank, 63 Steinmetz E, see Jespersen et al., 27, 33 Pisi E, see Bianchi et al., 385 Strewler GJ, see Marino et al., 205 Podzamczer D, Bolao F, Clotet B, Garcia P, Casanova A, Strom M, see Melander et al., 93 Pagerols X, Gudiol F. Low-dose interferon alpha combined Sundqvist G, see Ivarsson et al., 281 with zidovudine in patients with AIDS-associated Kaposi's Swainson CP, see Tan et al., 315 sarcoma, 247 Prytz H. Identification of alcoholic liver disease or hidden Tan SY, Nolan J, Craig K, Swainson CP. Supraventricular alcohol abuse in patients with elevated liver enzymes, 21 tachycardia, right atrial pressure, atrial natriuretic peptide Py6rala K, see Lehto et al.,179 and polyuria—a necessary sequence? (Case report), 415 Thybo NK, see Dorup et al., 117 Ramakrishna B, see Nayyar et al., 81 Torffvit O, Agardh C-D. Day and night variation in ambulatory Ranstam J, see Lindblad et al., 155 blood pressure in type 1 diabetes mellitus with nephropathy Rastam L, see Lindblad et al., 155 and autonomic neuropathy, 131 Renaud §, see de Lorgeril et al., 343 Troll W, see Pero et al., 69 Riboli E, see Callmer et al., 53 Tse KF, see Gallicchio et al., 259 Riis P. Scientific dishonesty—the need for precise concepts and Tuomilehto J, see Lehto et al., 179 effective tools (Editorial), 213 Tuomilehto J, Li N, Dowse G, Gareeboo H, Chitson P, Fareed D, Rodriguez-Villamil JL, see Del Rio & Rodriguez-Villamil, 409 Min Z, Alberti KGMM, Zimmet P. The prevalence of coronary Rondelli A, see Bianchi et al., 385 heart disease in the multi-ethnic and high diabetes Rossner S. Dietary fibre—no panacea (Editorial), 433 prevalence population of Mauritius, 187 Saleem SM, see Koul et al., 463 Unger J, Lambert M, Jonckheer MH, Denayer Ph. Amiodarone Salimonu LS, see Hedo et al., 467 and the thyroid: pharmacologocial, toxic and therapeutic Salomaa V, see Lehto et al.,179 effects (Review), 435 Sampedro I, see Farinas et al., 365 Sandstedt CS, see Myrenfors et al., 113 Valle R, see Castrillon et al., 89 Saracci R, see Callmer et al., 53 Valls R, see Monreal et al., 233 Saracci R. The Malm6 Diet and Cancer Study. Van Boven WPL, see Creemers et al., 85 (Minisymposium) Why should the relationship between diet Van der Heul C, see Creemers et al., 85 and cancer be investigated in prospective studies? 41 Schatzkin A, Freedman L, Schiffman M. The Malm6 Diet and Wallin A, see Landin et al., 357 Cancer Study (Minisympsoium). An epidemiologic perspective Wassmuth R, see Ivarsson et al., 281 on biomarkers, 75 Westheim A, see Os et al., 13 von Schenk H, see Attvall et al., 327 Wiklund O, see Berglund et al., 173 Schiano TD, see Herzlich & Schiano, 495 Williams RR, see Nayyar et al., 81 Schiffman M, see Schatzkin et al., 75 Schwan A, see Nilsson et al., 239 Yki-Jarvinen H, see Koivisto & Yki-Jarvinen, 145 Seidegard J, see Pero et al., 69 Sjdberg G, see Myrenfors et al., 113 Zimmet P, see Tuomilehto et al., 187 Skajaa K, see Dorup et al., 117 Zoli M, see Bianchi et al., 385 Journal of Internal Medicine 1993; 233: 509-512 Subject Index Abnormal haemoglobin, 299 Atrial natriuretic peptide Acute myocardial infarction, 139 and tachycardia, 415 Acute-phase reactants Audiogram and homozygous sickle cell disease, 467 during leukaemia treatment with amikacin, 401 Acute-phase response Autonomic neuropathy and lymphoma, 201 in diabetes mellitus, 131 ADH secretion Azathioprine SIADH and enalapril, 89 associated pure red cell aplasia, 85 AIDS and cerebral toxoplasmosis, 365 BFU-E and vitamin B,,, 495 and haematopoietic toxicity, 259 opportunistic infections, oesophagus, 107 Biological bank Alanine aminotransferase for the Malm6 Diet and Cancer Study, 45, 63 and mild hypertension, 477 Biological markers Alcohol relating diet and cancer, 41 and hepatic cytosolic oestrogen receptors, 165 Biomarker and serum liver enzyme activity, 477 linking diet and cancer, 63, 69, drinking—identification by elevated liver enzymes, 21 Blood cell fractionation Alcoholic liver diseases related to diet and cancer, 63 related to elevated liver enzymes, 21 Blood pressure Alzheimer’s disease in Alzheimer’s disease, 357 a metabolic disorder? 357 Caffeine Ambulatory blood pressure and ambulatory blood pressure, and treated hypertension, 351 Cancer day and night variation in diabetes mellitus, 131 related to diet, 41, 45 Amikacin Cardiovascular disease and hearing in leukaemia treatment, 401 absence of in Kitava, Melanesia, Amputation Cardiovascular diabetes and foot ulcers, 485 risk factors, 187 Anaemia Carnitine palmitoyltransferase (CPT) and unstable haemoglobin, 299 and acute renal failure, 295 associated with cyclosporin, 471 Catecholamines Anaphylactoid shock levels in essential hypertension, 13 and systemic mastocytosis, 255 Cervix dysplasia Anaphylaxis in cancer, 75 and systemic mastocytosis, 255 CFU-E Antibiotics and haematopoietic toxicity, 259 in myeloma, 419 CFU-Meg Anticardiolipid antibodies and haematopoietic toxicity, 259 and ischaemic heart disease, 291 Chemotherapy failure Anticoagulation of anti-tuberculous cancer after splenectomy, 81 and protein C deficiency, 287 Cholestyramine in acute myocardial infarction, 139 in hypercholesterolaemia, 173 Antiphospholipid syndrome Cholesterol and ischaemic heart disease, 291 in acute myocardial infarction, 179 Antiviral agents and hypertension, 239 in AIDS, 107 in hypercholesterolaemia, Apo E, 173 Aplasia Chronic liver disease pure red cell aplasia, 85 hepatic cytosolic oestrogen receptors in, 165 Apolipoprotein E Cirrhosis in familial hypercholesterolaemia, 173 vegetable versus animal protein diet in, 385 Arterial embolism Cohort study in acute myocardial infarction, 139 in the Skaraborg Hypertension Project, 155 Atherosclerosis Colonic polyps and enhanced platelet aggregation, 343 linking diet and cancer, 75 510 SUBJECT INDEX Congestive heart failure, 125 Fructose sensitivity Coronary angioplasty in diabetes, 145 and restenosis, 215 Coronary artery disease Gamma-glutamy] transferase and enhanced platelet aggregation, 343 and hypertension, 477 Coronary heart disease Gene expression in Mauritius, 187 related to diet and cancer, 69 serum cholesterol and HDL distributions in, 179 Glomerular filtration rate Coronary thrombosis in congestive heart failure, 125 and enhanced platelet aggregation, 343 Glucose levels Cox regression in Alzheimer’s disease, 357 and myocardial infarction, 393 Glycaemic control Crystalluria in diabetes, 145 in AIDS with toxoplasmosis, 365 GM-CSF severe methotrexate intoxication, 499 Deep vein thrombosis Growth hormone and post-thrombotic syndrome, 233 and insulin resistance, 327 Dementia, 357 Dementia complex Haematocrit AIDS and vitamin B,,, 495 in congestive heart failure, 125 Diabetes Haematopoietic and insulin therapy, 321 stem cells and toxicity, 259 education, 321 Haemoglobin, unstable fructose and insulin sensitivity in, 145 causing anaemia, 299 Diabetes mellitus Haemolytic anaemia ambulatory blood pressure in, 131 and unstable haemoglobin, 299 and coronary heart disease, 187 Hallucinogenic mushrooms and foot ulcers, 485 abuse by Danish students, 111 type I HLA-DR3, DQ2 homozygosity, 281 Heart transplantation Diet and diabetes, 321 and enhanced platelet aggregation, 343 Diet High-density lipoprotein linked with cancer, 41, 45, 53, 63, 69, 75 in acute myocardial infarction, 179 Disease severity Homozygous familial hypercholesterolaemia, 195 in homozygous sickle cell disease, 467 Hypoglycaemia Diuretics, 117 and diabetes, diet, insulin therapy, 321 DNA repair Hyperammonaemia related to diet and cancer, 69 and IgD multiple myeloma, 277 Drug abuse Hypercalcaemia hallucinogenic mushrooms, 111 in squamous/basal cell carcinoma, 205 Dyslipidaemia Hyperinsulinaemia and salt restriction in essential hypertension, 409 and salt restriction, 409 Dysphagia Hypertension in AIDS, 107 and caffeine, 351 effects of alcohol and obesity, 477 ECG and diabetes mellitus in diabetes mellitus, 131 and coronary heart disease, 187 sex differences in, 13 Electrocardiography, 269 the Skaraborg Hypertension Project, 155 Enalapril Hypokalaemia associated with SIADH, 89 in Kashmir, 463 Encephalopathy and IgD multiple myeloma, 27 / and vegetable versus animal protein diet, 385 Immunoglobulin A (serum) Epidemiology, 269 related to hidden alcohol abuse, 21 linking diet and cancer, 45, 75 Infarct location Erythropoietin significance, 393 and cyclosporin-associated anaemia, 471 Infarct type in congestive heart failure, 125 significance, 393 Europe Against Cancer, 41 Insulin antagonists Exercise test hormones, 327 in AMI, 33 Insulin resistance syndrome, 327 provoking ST-segment depression in AMI patients, 27 Insulin sensitivity in diabetes, 145 Foot ulcer Insulin therapy diabetes mellitus, 485 and diabetes, 321 SUBJECT INDEX Insulin-dependent diabetes mellitus Myocardial infarction and erythropoietin deficiency, 471 acute, 393 Interferon-« and serum cholesterol and HDL distribution, 179 and AIDS-associated Kaposi's sarcoma, 247 exercise-provoked ST-segment depression in, 27, 33 Interventions of restenosis Myoglobulinuria following coronary angioplasty, 215 and acute renal failure, 295 Intoxication methotrexate, 499 Nephropathy Ischaemic heart disease in diabetes mellitus, 131 and antiphospholipid antibodies, 291 Nitrogen balance and encephalopathy, 385 Kaposi’s sarcoma Nutrition AIDS-associated, 247 and stroke and ischaemic heart disease, 269 Keto-acidosis related to cancer, 41 and diabetes and insulin therapy, 321 Obesity Left ventricular thrombosis and hypertension, 477 in acute myocardial infarction, 139 related to essential hypertension, 13 Leukaemia Odynophagia hearing and amikacin treatment, 401 in AIDS, 107 Leukoaraiosis Oesophageal infections and Alzheimer’s, 357 in AIDS, 107 Lipid levels Oestrogen receptor in essential hypertension, 13 cytosolic, in liver disease, 165 Lipoprotein Ototoxicity in hypercholesterolaemia, 173 and amikacin, 401 and acute-phase response in lymphoma, 201 Overdose Lithium methotrexate, 499 and haematopoietic toxicity, 259 moclobemide, 113 Liver biopsy identification of hidden alcohol abuse, 21 Periodic paralysis Liver enzymes with sporadic distal renal tubular acidosis elevated in hidden alcohol abuse, 21 Plasma exchange Lupus anticoagulant and hypercholesterolaemia, 195 and ischaemic heart disease, 291 Platelet aggregation Lymphoma and coronary artery disease, 343 acute-phase response and associated lipoprotein Polymorphism abnormalities in, 201 related to diet and cancer, 69 Population Magnesium repletion, 117 and stroke and ischaemic heart disease, 269 Malignant neoplasm Potassium related to diet and cancer, 75 in skeletal muscle, 117 Mastocytosis Pravastatin and anaphylactoid shock, 255 in hypocholesterolaemia, 173 Mean corpuscular volume (MCV) Primary health care related to hidden alcohol abuse, 21 the Skaraborg Hypertension Project, Melanesia Primary prevention and absence of stroke and ischaemic heart disease, 269 the Skaraborg Hypertension Project, Meningeal myelomatosis Pro-oxidants /antioxidants and hyperammonaemic encephalopathy, 277 related to diet and cancer, 69 Metabolism Prognosis and Alzheimer’s disease, 357 in AMI, 27 Methods of the Malm6 Diet and Cancer Study, 53 Prospective studies Methotrexate intoxication, 499 relating diet and cancer, 41, 45 Minnesota Code, 187 Protein C deficiency Moclobemide overdose, 113 skin necrosis following warfarin, 287 Monoamine oxidase Psilocybine, 111 inhibitor type A, 113 PTH-rP Mortality in squamous/basal cell carcinoma, 205 and diabetes mellitus, 485 Pyomyositis in myocardial infarction, 393 in myeloma, 419 the Skaraborg Hypertension Project, 155 Myeloma Quality control programme and antibiotics, 419 of the Malm6 Diet and Cancer Study, 63 512 SUBJECT INDEX Questionnaires Sodium-potassium pumps relating to diet, 53 in skeletal muscle, 117 relating to drug abuse, 111 Splenic abcesses and failure of anti-tuberculous chemotherapy, 81 Renal blood flow Squamous cell carcinoma, 205 in congestive heart failure, 125 Staphyloccocus aureus Renal failure in myeloma with pyomyositis, 419 and carnitine palmitoyltransferase deficiency, Stroke Renal tubular acidosis the Skaraborg Hypertension Project, 155 and periodic hypokalaemic paralysis, 463 Students Renin drug abuse by, 111 in congestive heart failure, 125 Sulphadiazine —angiotensin system 351 in Aids patients with cerebral toxoplasmosis, 365 Restenosis Supraventricular tachycardia, 415 following coronary angioplasty, 215 Systemic antifungals Rhabdomyolysis in AIDS, 107 and acute renal failure, 295 Systemic mast cell disease, 255 Salt restriction Thromboembolism in essential hypertension, 409 in acute myocardial infarction, 139 Sclerosing cholangitis Trauma and diabetes mellitus type I, 281 related to hidden alcohol abuse, 21 Septicaemia Triglycerides and leukaemia treatment, 401 in hypercholesterolaemia, 173 Serum cholesterol and hypertension, 239 and hypercholesterolaemia, 195 Tuberculosis Sex differences chemotherapy failure, 81 related to essential hypertension, 13 Sex hormone receptors Ulcerative colitis in liver disease, 165 and diabetes mellitus type I, 281 Sickle cell anaemia and acute phase reactants, 467 Validation study Skeletal muscle of the Malmo Diet and Cancer Study, 53 magnesium, potassium, sodium—potassium pumps in, 117 Vegetable protein Skin necrosis in chronic encephalopathy, 385 following warfarin in protein C deficiency, 287 Venography, 233 Smoking Verapamil in AMI, 33 and hypertension, 239 Vitamin B,, and insulin resistance syndrome, 327 reversal of AIDS dementia complex, 495 Smooth muscle cells, 215 Snuffing Zidovudine and insulin resistance syndrome, 327 and haematopoietic toxicity, 259 therapy in AIDS-associated Kaposi's sarcoma, 247